Dmytro Kharkov

Dutch Bros adds Unicorn Blood to Halloween 2026 lineup: Can BROS continue gains?

Dutch Bros adds Unicorn Blood to Halloween 2026 lineup: Can BROS continue gains?
Dutch Bros jumps 4.16% on new launch

Dutch Bros (BROS) stock is trading at $42.86, gaining 4.16% on the day with high volatility and a strong close near its session high. The price is currently above its key short- and medium-term moving averages, reflecting solid momentum in the short run.

BROS price prediction
24H 0.27%
$43.94
48H -0.07%
$43.79
7D -1.69%
$43.08
1M 8.88%
$47.71
3M 24.26%
$54.45
6M 1.07%
$44.29
12M -22.8%
$33.83
Current price: $43.82 -0.0525 0.12%
Real-time Data 10:29
Daily range 43.89 Arrow from to Icon 44.00
Weekly range 42.18 Arrow from to Icon 45.17
Loading...

Highlights

  • Dutch Bros added the previously secret Unicorn Blood drink to its Halloween 2026 lineup, targeting existing fan demand.
  • Limited edition drinks historically generate spikes in customer visits and support short-term stock momentum.
  • Dutch Bros stock trades with strong short- and medium-term momentum, with an expected range of $40.32 to $45.4 in the coming days and overbought short-term indicators.

Seasonal product launch leverages cult following to lift demand

Dutch Bros has officially included the Unicorn Blood drink, a prior secret menu favorite, in its Halloween 2026 product lineup, according to Simplywall. This move capitalizes on the brand’s cult following and creates additional buzz around seasonal offerings, which may spur increased customer demand and higher store traffic. The strategic release of limited edition drinks often enhances short-term sales volume and supports a positive narrative for the stock’s momentum.

Dutch Bros Inc. asset chart
Dutch Bros Inc. price dynamics. Source: TradingView.

Uptrend momentum persists with supports rising but overbought risk

MA-20 is at $41.51 and MA-50 at $39.41, with both levels now acting as underlying support, while the MA-200 at $54.25 remains an overhead resistance zone. The Ichimoku Kijun is identified at $40.49 as immediate support. On the momentum side, MACD and ADX are both registering buy signals, while the RSI stands at an elevated 77.44 and CCI indicates overbought conditions. Bull/Bear Power reflects strong buyer dominance, whereas Stoch RSI and Awesome Oscillator both signal neutral. This constellation of technicals highlights significant momentum, but also heightened risk of a pullback due to extended oscillator readings.

Further price gains likely as resistance test drives short-term outlook

For the next few sessions, price action is expected to fluctuate within a volatility band between $40.32 and $45.4. The short-term forecast strongly favors an upward continuation, with a high probability of the stock pressing higher if resistance at $45.4 is breached. In contrast, a move below $40.32 would increase the likelihood of further declines toward lower support levels; however, the risk of this scenario currently appears minimal.

Anton Kharitonov, expert at Traders Union, notes that Dutch Bros stock is exhibiting strong momentum after a volatile session and sits well above near-term supports. The confirmed roll-out of Unicorn Blood for Halloween 2026 reinforces customer engagement, but technicals flag overbought risks with the RSI at 77.44. He sees a near-term upside bias as long as $40.32 holds, but any break below increases downside potential. "My base case is cautious: I respect the current momentum, but I want to see support at $40.32 hold before trusting further upside."

Earlier, analysts noted that Dutch Bros was demonstrating improved short-term momentum but remained within a volatile and technically indecisive trend. The latest breakout above key moving averages, supported by strong momentum indicators and elevated volatility, now places $45.40 as the critical resistance level to watch for confirmation of a sustained upward move.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.